Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.

about

Speciation of Phenanthriplatin and Its Analogs in the Core of Tobacco Mosaic Virus.Tuning the Optical Properties of Phenanthriplatin: Towards New Photoactivatable Analogues

P2860

Q52649156-54C9CA92-2695-4FC4-B568-DCDDA1725E7B Q56782217-5E4E8FFA-5A33-4A30-BB1A-5CCEBBC12283

P2860

Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.

Item

http://www.wikidata.org/entity/Q39824889

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Nucleotide Binding Preference ...... cancer-Agent Phenanthriplatin.

@en

Nucleotide Binding Preference ...... cancer-Agent Phenanthriplatin.

@nl

type

Item

label

Nucleotide Binding Preference ...... cancer-Agent Phenanthriplatin.

@en

Nucleotide Binding Preference ...... cancer-Agent Phenanthriplatin.

@nl

prefLabel

Nucleotide Binding Preference ...... cancer-Agent Phenanthriplatin.

@en

Nucleotide Binding Preference ...... cancer-Agent Phenanthriplatin.

@nl

P1476

Nucleotide Binding Preference ...... icancer-Agent Phenanthriplatin

@en

P2093

Ga Young Park

http://www.w3.org/2001/XMLSchema#string

Stephen J Lippard

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis

Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile

cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects

X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct

Structural and mechanistic studies of polymerase bypass of phenanthriplatin DNA damage

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA.

The challenge of deciphering linkage isomers in mixtures of oligomeric complexes derived from 9-methyladenine and trans-(NH3)2Pt(II) units.

Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.

DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.

P304

7574-7581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201600236

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Timothy C Johnstone

Imogen A Riddell

P577

2016-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27111128

http://www.w3.org/2001/XMLSchema#string

P932

4884344

http://www.w3.org/2001/XMLSchema#string

Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.

about

P2860

P2860

Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932